1. Barker E, Mueller BM, Handgretinger R, Herter M, Yu AL, Reisfeld RA (1991) Effect of a chimeric antiganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res 51: 144
2. Cheung NK, Landmeier B, Neely J, Nelson AD, Abramowsky C, Ellery S, Adams RB, Miraldi F (1986) Complete ablation with iodine131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J Natl Cancer Inst 77: 739
3. Cheung NK, Lazarus H, Miraldi F, Abramowsky C, Kallick S, Saarinen U, Spitzer T, Strandjord S, Coccia P, Berger N (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5: 1430
4. Conrad A, Schürmann J, Kreutz FH, Sieber A (1978) Elaboration of a method for the quantitative determination of proteins by laser nephelometry in the clinical routine laboratory. J Clin Chem Clin Biochem 16: 229
5. Dopfer R, Berthold F, Einsele H, Ehninger G, Klingebiel T, Handgretinger R, Bruchelt G, Niethammer D, Stollmann B, Rister M, Bender-Götze C (1989) Bone marrow transplantation in children with neuroblastoma. Folia Haematol 116: 427